Study guide
17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences
CCI Registered Cardiac Sonographer RCS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: RCS Orientation and Clinical Context
1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context
2 Chapter 2: Orders, Safety, and Patient Preparation
2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare
3 Chapter 3: Reporting and 2-D TTE Foundations
3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA
4 Chapter 4: M-Mode and Doppler Acquisition
4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition
5 Chapter 5: Advanced Doppler and Contrast
5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts
6 Chapter 6: Stress Echocardiography
6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation
7 Chapter 7: TEE, Strain, and 3-D TEE
7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts
8 Chapter 8: 3-D TTE and the Aortic Valve
8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States
9 Chapter 9: Aortic Regurgitation and Mitral Structure
9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability
10 Chapter 10: Mitral and Tricuspid Valve Findings
10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment
11 Chapter 11: Right-Sided Valve Disease
11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment
12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves
12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch
13 Chapter 13: Endocarditis and Cardiac Chambers
13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function
14 Chapter 14: Cardiomyopathy Phenotypes and Diastology
14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls
15 Chapter 15: Systolic Function and Ischemia
15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications
16 Chapter 16: Pericardium and Great Vessels
16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation
17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition
17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues
18 Chapter 18: Devices, Strain, and Hemodynamics
18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts
19 Chapter 19: Infiltrative Disease and Physics Foundations
19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing
20 Chapter 20: Resolution and Doppler Optimization
20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain
21 Chapter 21: 2-D, 3-D, and Contrast Optimization
21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts
17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences
Key Takeaways Explain This Topic AI
Echo estimates PH probability and RV consequences, while invasive hemodynamics define PH and distinguish pre- from postcapillary physiology when clinically required.
RVSP equals 4(TR velocity)² plus RAP only when the TR envelope is complete and aligned; it approximates PASP only without pulmonic or RVOT obstruction.
IVC-based RAP categories require spontaneous breathing and are qualified by effort, ventilation, abdominal pressure, athletic adaptation, volume change, and supportive venous findings.
Septal timing, RV remodeling and function, PA/RVOT patterns, PR, RA/venous congestion, left-heart disease, shunts, and loading must corroborate any pressure estimate.
Last updated: July 2026
Separate invasive diagnosis from echo probability
Pulmonary hypertension, or PH, is defined invasively by mean pulmonary artery pressure greater than 20 mm Hg at rest. Echocardiography estimates pressure, identifies consequences, and raises or lowers probability; it does not replace right-heart catheterization or independently assign a PH group. Review symptoms, oxygen or ventilator state, blood pressure, rhythm, lung disease, thromboembolic risk, congenital shunt, valve disease, and LV systolic and diastolic findings. The same PASP can have different causes and consequences, while a technically invalid low estimate cannot exclude disease.
Acquire a complete right-heart dataset: RV-focused apical size and function, RA-focused size, TR from multiple windows, pulmonic and RVOT anatomy, septal shape, PA size and flow, IVC, hepatic veins, and left-heart or shunt clues. Record respiration and loading. Acute pressure overload may produce RV dilation and dysfunction without hypertrophy; chronic load can add wall thickening, RA enlargement, secondary TR, and systemic venous congestion.
Calculate RAP and RVSP only from valid inputs
In a spontaneously breathing adult, measure IVC diameter at end-expiration approximately 0.5–3 cm from the RA junction, distal to the hepatic-vein entry. Observe quiet inspiration and a sniff when appropriate. Apply the standard categories as a starting point:
- IVC finding Estimated RAP Qualification
- Diameter ≤2.1 cm and collapse ≥50% 3 mm Hg Normal range; use 0–5 mm Hg when a range is required
- Diameter >2.1 cm and collapse <50% 15 mm Hg High range; supportive venous findings improve confidence
Diameter and collapse are discordant 8 mm Hg Intermediate default; integrate RA size, hepatic veins, and clinical context
Positive-pressure ventilation disrupts the usual collapse relationship. Poor inspiratory effort, elevated intra-abdominal pressure, athletic adaptation, recent fluid change, and inability to visualize the true IVC also limit RAP. Do not select RAP merely to make the final pressure look plausible. Report when the estimate has low confidence.
Obtain CW Doppler through TR from apical, parasternal, RV inflow, and subcostal windows. Align parallel to the jet and save the highest reproducible complete envelope without angle correction. Then calculate:
RVSP = 4(TR peak velocity)² + RAP
A TR velocity of 3.2 m/s gives 4 × 3.2² = 41 mm Hg; adding RAP of 8 mm Hg gives RVSP about 49 mm Hg. Only when no pulmonic-valve or RVOT obstruction exists may RVSP approximate PASP. With obstruction, the value describes RV systolic load and must not be labeled PASP. Use an enhancing agent under laboratory protocol when it can complete a weak envelope, but trace the modal border rather than isolated bright noise.
An incomplete or misaligned TR envelope underestimates velocity, and velocity error is squared. Excessive gain, spectral artifact, or tracing a faint outer edge can overestimate. Severe free TR may cause early RV-RA pressure equalization and underestimate the gradient; RAP may also be less reliable. If no adequate TR signal exists, state that RVSP cannot be estimated rather than assigning a normal pressure. A resting TR velocity at least 2.9 m/s, or at least 2.8 m/s with two or more supportive echo signs, suggests PH, but signal quality and the integrated pattern remain essential.
Integrate adjunctive pressure signs
Region Pressure-load clue Important alternative or limitation
Interventricular septum Systolic flattening or LV eccentricity index >1 Volume load predominates when flattening is mainly diastolic; conduction can alter motion
RV Dilation, hypertrophy, reduced FAC, TAPSE, S′, strain, or 3-D RVEF Acute versus chronic timing and load change the phenotype
PA/RVOT Dilated PA, shortened acceleration time, midsystolic notching Flow, heart rate, sample position, and lung disease affect patterns
PR Doppler Elevated end-diastolic or mean PA pressure estimate when a complete signal is present Alignment, RAP assumption, and poor PR envelope limit calculation
RA/systemic veins RA enlargement, dilated IVC, abnormal hepatic-vein flow TR, ventilation, AF, and volume state are confounders
RV-PA coupling adds context. TAPSE/PASP relates a basal longitudinal contraction surrogate to estimated afterload; lower values suggest inadequate adaptation, but the ratio inherits every error in both inputs and is not a direct pressure-volume measurement. Assess FAC, S′, 3-D RVEF or strain when available, cardiac output, and TR rather than allowing one normal TAPSE to erase other dysfunction.
Describe consequences and possible cause
Pressure overload first increases RV wall stress and septal interaction. Progressive maladaptation produces RV dilation, reduced output, RA enlargement, functional TR, elevated RAP, pericardial effusion, and systemic congestion. A small hyperdynamic LV can reflect underfilling rather than primary LV disease. Compare serial studies under similar oxygenation, ventilation, rhythm, blood pressure, and therapy because afterload and preload can change rapidly.
Search for left-heart disease, valve lesions, intracardiac shunts, chronic thromboembolic clues, and congenital or RVOT obstruction. Echo can suggest postcapillary physiology through LA enlargement, LV hypertrophy, valve disease, or filling evidence, but cannot definitively distinguish pre- from postcapillary PH. Report peak TR velocity, RAP method and confidence, calculated RVSP, whether PASP equivalence is valid, supportive signs, RV adaptation, and limitations. Acute RV failure, a thrombus in transit, suspected acute pulmonary embolic physiology, or severe hemodynamic compromise requires immediate communication through laboratory policy.
Verify serial pressure change
Before declaring progression or improvement, compare the same TR window and envelope quality, RAP method, rhythm, oxygenation, ventilation, blood pressure, and loading state. A change created by a different Doppler border or IVC assumption is measurement disagreement, not proven pulmonary vascular change.
No complete TR envelope, no numeric RVSP
A partial or misaligned signal is not repaired by tracing its faint edge. Report that RVSP cannot be estimated and use the full right-heart pattern; absence of a measurable jet does not prove normal pulmonary pressure.